{"id":229240,"date":"2025-05-27T19:24:40","date_gmt":"2025-05-27T19:24:40","guid":{"rendered":"https:\/\/evertise.net\/?p=117846"},"modified":"2025-05-27T19:24:40","modified_gmt":"2025-05-27T19:24:40","slug":"deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/","title":{"rendered":"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025"},"content":{"rendered":"<p><span id = wx_e_117846><\/span><\/p>\n<p><b>Seattle, United States<\/b><span style=\"font-weight: 400\"> \u2014 <\/span><a href=\"https:\/\/x-doc.ai\/\"  rel=\"noopener\"><i><span style=\"font-weight: 400\">Deep Intelligent Pharma (DIP)<\/span><\/i><\/a><span style=\"font-weight: 400\"> has officially launched a groundbreaking generative AI platform that promises to redefine how the world develops medicine. Unveiled today at <\/span><b>Microsoft Build 2025<\/b><span style=\"font-weight: 400\">, where <\/span><a href=\"https:\/\/x-doc.ai\/\"  rel=\"noopener\"><span style=\"font-weight: 400\">DIP<\/span><\/a><span style=\"font-weight: 400\"> was the <\/span><b>exclusive presenter from Asia<\/b><span style=\"font-weight: 400\">, the new solution represents a bold leap forward in the fusion of AI and life science innovation.<\/span><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-117847\" src=\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg\" alt=\"\" width=\"2048\" height=\"1151\" srcset=\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg 2048w, https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7-300x169.jpg 300w, https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7-1024x576.jpg 1024w, https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7-768x432.jpg 768w, https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7-1536x863.jpg 1536w\" sizes=\"(max-width: 2048px) 100vw, 2048px\" \/><\/p>\n<p><span style=\"font-weight: 400\">Built in partnership with <\/span><b>Microsoft Azure O3<\/b><span style=\"font-weight: 400\">, DIP\u2019s next-gen platform harnesses <\/span><b>multi-agent AI swarms<\/b><span style=\"font-weight: 400\"> capable of performing scientific writing, statistical reasoning, document validation, and regulatory compliance with <\/span><b>superhuman scale and precision<\/b><span style=\"font-weight: 400\">. It directly targets one of the most expensive, slow, and error-prone challenges in pharma: the creation of clinical and regulatory documents.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cThis isn\u2019t just an upgrade \u2014 it\u2019s a reinvention of how life science companies operate,\u201d said <\/span><b>Xing Li<\/b><span style=\"font-weight: 400\">, CEO of <\/span><a href=\"https:\/\/www.dip-ai.com\/\"  rel=\"noopener\"><span style=\"font-weight: 400\">DIP<\/span><\/a><span style=\"font-weight: 400\">. \u201cWe\u2019ve turned months of expert labor into minutes of AI-driven intelligence \u2014 bringing speed, accuracy, and scientific depth into perfect alignment.\u201d<\/span><\/p>\n<h2><b>A Paradigm Shift in Life Science R&#038;D<\/b><\/h2>\n<p><span style=\"font-weight: 400\">The DIP platform is designed to eliminate the longstanding bottlenecks of pharmaceutical development:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><b>90%+ reduction<\/b><span style=\"font-weight: 400\"> in documentation time<\/span><\/li>\n<li style=\"font-weight: 400\"><b>75% faster<\/b><span style=\"font-weight: 400\"> regulatory submissions<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Zero-defect document generation<\/b><span style=\"font-weight: 400\"> through statistical and methodological inference<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Seamless parsing of complex formats like tables, PDFs, and legacy data silos<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Real-time consistency checks across massive, multi-document workflows<\/span><\/li>\n<\/ul>\n<h2><b>Real Results, Real Impact<\/b><\/h2>\n<p><span style=\"font-weight: 400\">At Build, DIP showcased a live case study in which its AI-authored protocol for a novel cancer immunotherapy was <\/span><b>approved by Japan\u2019s PMDA with zero revisions \u2014 in a single review cycle<\/b><span style=\"font-weight: 400\">. The message was clear: generative AI isn\u2019t the future of pharma \u2014 it\u2019s happening now.<\/span><\/p>\n<p><span style=\"font-weight: 400\">With over <\/span><b>1,000 pharma clients<\/b><span style=\"font-weight: 400\">, <\/span><b>20,000+ submission projects<\/b><span style=\"font-weight: 400\">, and <\/span><b>5 billion words processed<\/b><span style=\"font-weight: 400\">, DIP is already trusted by industry leaders across Asia and beyond. And now, it\u2019s setting a new global standard for how data becomes discovery.<\/span><\/p>\n<h2><b>Transforming the Economics of Innovation<\/b><\/h2>\n<p><span style=\"font-weight: 400\">With drug development costs surpassing <\/span><b>$2 billion per therapy<\/b><span style=\"font-weight: 400\"> and timelines stretching 10\u201315 years, DIP\u2019s AI orchestration radically accelerates innovation \u2014 helping companies reinvest resources into science instead of paperwork.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cThis is AI that thinks like a scientist, writes like a regulator, and moves at the speed of discovery,\u201d added Shinya Yamamoto. \u201cWe\u2019re not just helping companies go faster \u2014 we\u2019re helping them aim higher.\u201d<\/span><\/p>\n<h2><b>About Deep Intelligent Pharma<\/b><\/h2>\n<p><span style=\"font-weight: 400\">Founded in 2017, <\/span><a href=\"https:\/\/x-doc.ai\/\"  rel=\"noopener\"><span style=\"font-weight: 400\">Deep Intelligent Pharma<\/span><\/a><span style=\"font-weight: 400\"> is a pioneering AI company with global offices in Japan, China, and Singapore. Its mission is to empower pharmaceutical and medtech innovators through intelligent automation, turning regulatory complexity into a catalyst for speed, scale, and scientific excellence. DIP has built agent swarms based on generative AI models with outcome based payment model in life science R&#038;D.\u00a0<\/span><\/p>\n<p><b>Media Contact<\/b><\/p>\n<p><span style=\"font-weight: 400\">Company Name: Deep Intelligent Pharma<\/span><\/p>\n<p><span style=\"font-weight: 400\">Contact Person: Xing Li<\/span><\/p>\n<p><span style=\"font-weight: 400\">Email: bd@dip-ai.com<\/span><\/p>\n<p><span style=\"font-weight: 400\">Country: Singapore<\/span><\/p>\n<p><span style=\"font-weight: 400\">Website: <\/span><a href=\"https:\/\/x-doc.ai\/\"  rel=\"noopener\"><span style=\"font-weight: 400\">https:\/\/x-doc.ai\/<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span><\/span>Seattle, United States \u2014 Deep Intelligent Pharma (DIP) has officially launched a groundbreaking generative AI platform that promises to redefine how the world develops medicine. <a href=\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-229240","post","type-post","status-publish","format-standard","hentry","category-ips"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business\" \/>\n<meta property=\"og:description\" content=\"Seattle, United States \u2014 Deep Intelligent Pharma (DIP) has officially launched a groundbreaking generative AI platform that promises to redefine how the world develops medicine. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-27T19:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg\" \/>\n<meta name=\"author\" content=\"Evertise\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Evertise\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\",\"name\":\"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg\",\"datePublished\":\"2025-05-27T19:24:40+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage\",\"url\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg\",\"contentUrl\":\"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca\",\"name\":\"Evertise\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g\",\"caption\":\"Evertise\"},\"sameAs\":[\"http:\/\/evertise.net\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/evertise\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/","og_locale":"en_US","og_type":"article","og_title":"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business","og_description":"Seattle, United States \u2014 Deep Intelligent Pharma (DIP) has officially launched a groundbreaking generative AI platform that promises to redefine how the world develops medicine. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/","og_site_name":"Business","article_published_time":"2025-05-27T19:24:40+00:00","og_image":[{"url":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg","type":"","width":"","height":""}],"author":"Evertise","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Evertise","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/","url":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/","name":"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg","datePublished":"2025-05-27T19:24:40+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#primaryimage","url":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg","contentUrl":"https:\/\/evertise.net\/wp-content\/uploads\/2025\/05\/7.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2025\/05\/27\/deep-intelligent-pharma-unleashes-a-new-era-of-ai-driven-drug-development-at-microsoft-build-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Deep Intelligent Pharma Unleashes a New Era of AI-Driven Drug Development at Microsoft Build 2025"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/02176def5777c27b30102772b94615ca","name":"Evertise","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d79ec50bebdc68a4ebc6cfc341e0920ba7b507bde39945491ca6dec05d097ed7?s=96&d=mm&r=g","caption":"Evertise"},"sameAs":["http:\/\/evertise.net"],"url":"https:\/\/ipsnews.net\/business\/author\/evertise\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/229240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=229240"}],"version-history":[{"count":4,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/229240\/revisions"}],"predecessor-version":[{"id":230374,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/229240\/revisions\/230374"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=229240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=229240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=229240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}